Green Thumb Industries (GTII): MSO Profile, Brands, Markets and Stock
Green Thumb Industries (CSE: GTII, OTCQX: GTBIF) is a Chicago-based U.S. multistate cannabis operator (MSO). It cultivates, manufactures, and sells cannabis through its RISE Dispensaries and a portfolio of consumer brands. This hub covers the company's history, brands, state footprint, and how it reports financials. It also explains how the stock trades, what drives MSO valuation multiples, and how federal policy such as rescheduling and Section 280E affects results. It tracks news including buyback announcements and quarterly earnings calls, with answers to the questions investors and cannabis consumers ask most.
Executive summary
Green Thumb Industries (CSE: GTII; OTCQX: GTBIF) is a Chicago-based multi-state operator that grew from a 2014 startup into one of the largest U.S. cannabis companies, and a $50 million buyback headline on September 24, 2026 put its capital-allocation story back in front of investors. According to a kalkine.ca report dated that day, GTII shares rose 8.29% on the Canadian Securities Exchange. The report tied the move to a $50M share repurchase program, an upcoming third-quarter earnings call date, and a debate over whether MSO valuation multiples are due for a re-rating.
GTI is a vertically integrated MSO. It cultivates and manufactures cannabis products, sells them under house brands such as Rythm, Dogwalkers, incredibles, Beboe, &Shine and Doctor Solomon's, and retails them through its RISE dispensaries and other storefronts. It files with the SEC under U.S. GAAP and has reported annual revenue of roughly $1 billion in recent years. Its footprint is concentrated in limited-license markets, including Illinois, Pennsylvania, Ohio, New Jersey, New York and Massachusetts.
Three variables drive how investors value GTI and its peers:
- Federal tax treatment under 280E. This depends on rescheduling.
- State wholesale price compression. It erodes margins in maturing markets.
- Capital discipline. This covers buybacks, debt and expansion spending.
This page sets out GTI's history, structure, legal exposure, state footprint and the decision points ahead. It is a foundation that will be extended with dated updates. Confirm the buyback's terms (size, duration, mechanics) in GTI's own filings and press releases before acting on them.
Why this matters
GTI is a bellwether: its results, balance sheet and capital choices are read across the whole U.S. plant-touching sector.
Plant-touching U.S. operators cannot list on NYSE or Nasdaq while marijuana remains federally illegal. Canadian and OTC venues therefore carry the sector's price discovery, and GTI is one of the few names with scale, consistent profitability and a relatively conservative balance sheet. When it announces a buyback, investors take it as a statement about how management values its own stock against alternatives such as acquisitions, new licenses or debt paydown.
Who is affected
- Shareholders and bondholders: a buyback shrinks the share count, but only if it is executed rather than merely authorized.
- Competing MSOs: GTI's multiple becomes a reference point for peers such as Curaleaf, Trulieve, Verano and Cresco.
- Brand partners and wholesale customers: GTI's brands sit on third-party shelves in several states.
- Employees and communities: GTI employs thousands of people and operates social equity and community programs.
- Patients and adult-use consumers: in medical-only markets such as Pennsylvania and Florida, GTI is a primary supplier.
Scale in context
A $50 million authorization is small beside GTI's roughly $1 billion in annual revenue, but it matters as a signal. A buyback equal to 3% of market capitalization would need a market cap of about $1.67 billion. That figure is purely illustrative, since GTI's actual market cap moves daily. Readers should divide $50M by the live market cap to see the true percentage retired if the program is fully used.
Background and history
GTI went from a 2014 Illinois license applicant to a public, SEC-reporting, billion-dollar-revenue operator in about eight years.
2014: Founding in Chicago
Ben Kovler founded Green Thumb Industries in 2014, when Illinois was building its medical cannabis pilot program. The company won licenses and began building cultivation and retail capacity in a state with strict caps. Its early strategy leaned on limited-license markets, where regulators award a fixed number of permits and incumbents enjoy structural protection.
2015–2017: Building the RISE retail platform
GTI developed RISE as its retail banner and consumer brands in parallel, so it could capture margin at both ends of the value chain. Medical programs in states including Pennsylvania and Ohio offered early footholds. Pennsylvania's limited-permit structure and Ohio's licensing round gave vertically integrated operators durable positions.
2018: Canadian listing
GTI listed on the Canadian Securities Exchange under the ticker GTII in 2018 and later added OTCQX quotation under GTBIF for U.S. investors. Because Canadian exchanges permitted U.S. cannabis issuers with proper disclosure, the CSE became the sector's main capital-raising venue. That route shaped GTI's investor base and disclosure habits.
2019–2020: Adult-use arrives in Illinois
Illinois launched adult-use sales on January 1, 2020, after the Cannabis Regulation and Tax Act. For a Chicago-headquartered operator this was a defining moment, and Illinois became one of GTI's core revenue states. The same period saw GTI strengthen its U.S. regulatory posture and begin SEC reporting alongside its Canadian filings.
2021–2022: Scale and profitability
Revenue approached and then reached about $1 billion annually. GTI stood out among MSOs for positive operating cash flow and adjusted EBITDA margins in the high-20s percent range, according to its public financial reporting. It also built out its footprint through acquisitions and organic expansion in New Jersey, New York, Maryland, Virginia, Connecticut and Rhode Island. Verify current state-by-state store counts in the most recent 10-K or 10-Q.
2023–2024: New markets, price pressure
Voters in Ohio approved adult-use in November 2023, and sales began in August 2024. Maryland started adult-use sales on July 1, 2023, and Minnesota legalized adult-use in August 2023. New openings brought growth but also price compression. Wholesale flower prices fell in several mature markets as supply caught up with demand.
May 2024: The federal rescheduling proposal
In May 2024 the U.S. Department of Justice and the DEA published a NPRM proposing to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (21 U.S.C. § 812). An administrative hearing before an ALJ was scheduled and then postponed in early 2025. Schedule III status would not legalize cannabis federally. It would, however, change the tax picture for operators like GTI. See the legal section below.
September 2026
Frequently asked questions
What is Green Thumb Industries?
Green Thumb Industries (GTI) is a vertically integrated U.S. cannabis company headquartered in Chicago, Illinois. It cultivates and manufactures cannabis products, sells them wholesale to third-party retailers, and sells them directly to consumers through its own RISE Dispensaries. Ben Kovler founded the company in 2014. It is classed as a multistate operator (MSO) because it holds licenses across many U.S. states.
What is Green Thumb's stock ticker?
GTI's shares trade on the Canadian Securities Exchange under GTII and on the U.S. OTCQX market under GTBIF. Because cannabis remains federally illegal in the U.S., the stock is not listed on the NYSE or Nasdaq. Quotes on Canadian and U.S. venues are in different currencies, so check which one you are viewing.
What brands does Green Thumb own?
GTI's consumer portfolio includes Rythm (flower and vapes), Dogwalker (pre-rolls), incredibles (edibles), Beboe (a premium lifestyle brand), Good Green, &Shine, and Doctor Solomon's. Products are sold in its RISE Dispensaries and through wholesale partners. Brand availability varies by state, depending on local licensing and product rules.
Where does Green Thumb operate?
GTI operates in a number of U.S. states, with large positions in Illinois, Pennsylvania, Ohio, New Jersey, Massachusetts, Nevada, Florida, Maryland, Minnesota, and New York. Its footprint mixes adult-use and medical-only markets, and it changes as licenses are won, acquired, or sold. Check GTI's latest SEC filings for the current store and license count.
Does Green Thumb report to the SEC?
Yes. Despite trading on the CSE and OTCQX, GTI files periodic reports with the U.S. Securities and Exchange Commission, including 10-Ks and 10-Qs, and reports in U.S. dollars under U.S. GAAP. Investors can read these filings on SEC EDGAR or on the company's investor relations site for audited financials, risk factors, and state-by-state disclosures.
Has Green Thumb announced a share repurchase program?
Recent coverage from Kalkine, dated September 2026, reported a $50 million share repurchase program alongside a stock move of roughly 8%. Buyback terms such as duration, pricing, and funding are set out in GTI's official press releases and SEC filings. Confirm details there rather than relying on secondary summaries.
When does Green Thumb report quarterly earnings?
GTI typically releases quarterly results with a conference call and webcast for investors. The company announces call dates in advance through press releases and its investor relations page. Results cover revenue, gross margin, adjusted EBITDA, cash flow, and state-level commentary. Check the investor relations calendar for the confirmed Q3 date.
How does Section 280E affect Green Thumb?
Section 280E of the U.S. tax code bars businesses that traffic in Schedule I or II controlled substances from deducting ordinary business expenses. Because cannabis is still federally controlled, MSOs such as GTI often pay high effective tax rates. Federal rescheduling to Schedule III would remove 280E for cannabis, which is why tax policy news moves MSO stocks.
Why do MSO valuation multiples matter for GTI?
Investors usually value MSOs on enterprise value to EBITDA and similar multiples because many carry tax burdens and limited access to capital markets. When federal reform looks likelier, multiples can re-rate higher. When it stalls, they compress. GTI is often seen as a quality operator in this group, but its multiple still moves with sector sentiment.
Can U.S. investors buy Green Thumb stock?
Yes. U.S. investors can generally buy GTBIF on the OTCQX through brokerages that support OTC trading, and some also offer the CSE listing, GTII. Liquidity, fees, and currency handling vary by broker. Cannabis equities are volatile and carry regulatory risk, so check your broker's access and review GTI's filings before investing.
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.